Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 89% ± 14% | |
lung | 18 studies | 79% ± 17% | |
intestine | 12 studies | 82% ± 17% | |
brain | 12 studies | 34% ± 21% | |
eye | 10 studies | 49% ± 25% | |
kidney | 9 studies | 77% ± 19% | |
liver | 7 studies | 62% ± 30% | |
bone marrow | 6 studies | 85% ± 12% | |
pancreas | 5 studies | 81% ± 20% | |
lymph node | 5 studies | 95% ± 3% | |
uterus | 5 studies | 88% ± 15% | |
placenta | 4 studies | 83% ± 28% | |
adipose | 4 studies | 46% ± 29% | |
esophagus | 4 studies | 64% ± 32% | |
prostate | 4 studies | 83% ± 26% | |
breast | 4 studies | 91% ± 4% | |
heart | 3 studies | 42% ± 17% | |
skin | 3 studies | 74% ± 26% | |
stomach | 3 studies | 51% ± 29% | |
thymus | 3 studies | 75% ± 32% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 19602.27 | 1445 / 1445 | 100% | 252.58 | 183 / 183 |
ovary | 100% | 31673.34 | 180 / 180 | 100% | 606.16 | 430 / 430 |
pancreas | 100% | 18544.48 | 328 / 328 | 100% | 337.81 | 178 / 178 |
skin | 100% | 28067.04 | 1809 / 1809 | 100% | 461.65 | 472 / 472 |
uterus | 100% | 22357.85 | 170 / 170 | 100% | 448.14 | 459 / 459 |
thymus | 100% | 17132.87 | 652 / 653 | 100% | 385.04 | 605 / 605 |
prostate | 100% | 19870.32 | 245 / 245 | 100% | 410.72 | 501 / 502 |
brain | 100% | 13039.64 | 2634 / 2642 | 100% | 315.54 | 705 / 705 |
stomach | 100% | 16307.62 | 359 / 359 | 100% | 365.52 | 285 / 286 |
intestine | 100% | 19576.51 | 966 / 966 | 100% | 419.15 | 525 / 527 |
adrenal gland | 100% | 18864.98 | 258 / 258 | 100% | 292.90 | 229 / 230 |
liver | 100% | 10231.42 | 225 / 226 | 100% | 298.51 | 406 / 406 |
kidney | 100% | 17751.03 | 89 / 89 | 99% | 267.33 | 895 / 901 |
bladder | 100% | 21413.76 | 21 / 21 | 99% | 406.45 | 500 / 504 |
lung | 100% | 19211.17 | 577 / 578 | 99% | 321.60 | 1147 / 1155 |
breast | 100% | 23899.12 | 459 / 459 | 99% | 352.63 | 1107 / 1118 |
adipose | 100% | 23571.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 705.41 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 917.83 | 29 / 29 |
muscle | 100% | 20890.43 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 51575.56 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 25031.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 412.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 370.76 | 1 / 1 |
blood vessel | 100% | 21194.39 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 12906.62 | 849 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0019941 | Biological process | modification-dependent protein catabolic process |
GO_0036211 | Biological process | protein modification process |
GO_0002181 | Biological process | cytoplasmic translation |
GO_0005615 | Cellular component | extracellular space |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0022627 | Cellular component | cytosolic small ribosomal subunit |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0022625 | Cellular component | cytosolic large ribosomal subunit |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0031982 | Cellular component | vesicle |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0031386 | Molecular function | protein tag activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0005515 | Molecular function | protein binding |
Gene name | UBA52 |
Protein name | Ubiquitin-ribosomal protein eL40 fusion protein (CEP52) (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40)] Ubiquitin A-52 residue ribosomal protein fusion product 1 Ubiquitin-ribosomal protein eL40 fusion protein (Ubiquitin A-52 residue ribosomal protein fusion product 1) |
Synonyms | UBCEP2 hCG_37048 |
Description | FUNCTION: [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in proteotoxic stress response and cell cycle; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. .; FUNCTION: [Large ribosomal subunit protein eL40]: Component of the 60S subunit of the ribosome . Ribosomal protein L40 is essential for translation of a subset of cellular transcripts, and especially for cap-dependent translation of vesicular stomatitis virus mRNAs . . FUNCTION: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-48-linked is involved in protein degradation via the proteasome. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. . FUNCTION: Component of the 60S subunit of the ribosome. .; FUNCTION: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-48-linked is involved in protein degradation via the proteasome. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. . |
Accessions | ENST00000594527.1 M0R1V7 P62987 M0R1M6 ENST00000596273.5 ENST00000430157.6 ENST00000595683.5 ENST00000597451.5 Q3MIH3 M0R2S1 ENST00000599256.5 ENST00000599551.5 ENST00000442744.7 ENST00000596272.5 ENST00000595158.5 ENST00000598780.5 ENST00000599595.5 ENST00000596304.5 |